Hook & thesis
Markets have swung from AI exuberance to AI skepticism, leaving high-quality information franchises like RELX trading well below prior peaks. That selloff is the 'SaaSpocalypse' — a fear-driven de-rating of subscription-oriented businesses — but RELX's fundamentals argue the company should weather the storm better than many pure-software peers.
My trade thesis: buy RELX at current levels as a mid-term recovery trade. The company sells mission-critical information and analytics to legal, scientific, risk and insurance customers with sticky recurring contracts and evident pricing power (legal partner rates rose in 2025). Technicals show bullish momentum and the dividend plus a modest valuation give a safety cushion. Entry $36.33, stop $33.00, target $44.00 for a mid-term hold (45 trading days).
What RELX does and why it matters
RELX plc is a global information and analytics provider with distinct segments: Scientific, Technical & Medical; Risk; Legal; Exhibitions; and Print & print-related. These are not throwaway SaaS apps: they supply content, curated datasets and analytics that customers embed into regulated workflows — legal briefs, litigation analytics, risk underwriting, and scientific research. That makes churn lower and pricing stickier than consumer-grade software.
Investors should care because the underlying markets are expanding and increasingly budgeted. Market research projects the global business information market to grow from roughly $192 billion in 2025 toward $306.6 billion by 2033, and niche markets like insurance analytics are forecast to expand even faster. That market backdrop underpins sustainable demand for RELX's analytics and subscription services.
Evidence from the tape and company signals
- Customer momentum: Public wins and deployments demonstrate enterprise adoption — LexisNexis rolled out a firm-wide implementation at Dentons in the UK (03/25/2026), and the LexisNexis CounselLink 2026 Trends Report (04/22/2026) highlights rising partner rates and concentration of spend at large law firms. Those datapoints signal pricing power and enterprise entrenchment.
- Sector tailwinds: Rising litigation activity and regulatory demands (Lex Machina report on employment litigation, 03/10/2026) create more demand for analytics and litigation tools.
- Balance of capital markets signals: RELX trades at $36.33 with a market capitalization around $64.8 billion, a forward-looking P/E of about 24.8, and a dividend yield near 2.36%. The stock sits well above near-term moving averages (10-day SMA $36.01, 20-day SMA $34.61, 50-day SMA $33.76) and the 9-day EMA ($35.96), while RSI sits a constructive ~62.97 — momentum is intact.
- Short selling: Short interest and short-volume data indicate modest friction for downside squeezes — days-to-cover has been near 1 and intraday short volume has been significant on high-volume sessions, which can amplify moves higher if buying returns.
Valuation framing
At a market cap of roughly $64.8 billion and a P/E around 24.8, RELX is no deep-value bargain, but it is not priced for perfection either. The stock is off its 52-week high of $56.33 and well above its 52-week low of $27.565, reflecting a market that has rebalanced expectations. A few qualitative points:
- RELX carries a high P/B around 21.00 — this is usually a sign that much of the balance sheet value is intangible (software, content libraries, databases) that investors are willing to pay a premium for because it generates persistent, recurring cash flows.
- Dividend yield near 2.36% (semi-annual distribution of $0.65592 per share; ex-dividend 05/08/2026; payable 06/24/2026) provides income while waiting for multiple expansion or earnings acceleration.
- Compared to hype-driven software peers, RELX's revenues are more resilient to churn and more defendable due to regulatory and professional workflow integration, which supports a higher-than-average multiple, in my view.
Trade plan (actionable)
This is a mid-term directional long that targets a recovery into the prior trading range while maintaining a disciplined stop to limit downside.
| Parameter | Value |
|---|---|
| Entry | $36.33 |
| Stop | $33.00 |
| Target | $44.00 |
| Horizon | mid term (45 trading days) |
| Risk level | medium |
Rationale: $44.00 is a realistic recovery target that sits below the 52-week high and represents roughly a 21% upside from entry; the $33.00 stop limits downside to about 9% and keeps position sizing manageable if sentiment worsens. Expect the hold to last up to 45 trading days as sentiment normalizes and product deployments and pricing signals translate into visible revenue momentum.
Catalysts
- Customer rollouts and product deployments at global law firms and insurers (e.g., further LexisNexis expansions) that validate cross-sell and data consolidation benefits.
- Quarterly results or interim KPI updates showing continued subscription growth and stable/expanding margins.
- Macro support from the UK economy easing and lower rates, which would boost enterprise spend and investor risk appetite (UK growth showed signs of stabilization in early 2026).
- Industry reports highlighting growth in business information and analytics markets, reinforcing long-term TAM expansion (market projections through 2033).
Risks and counterarguments
No trade is without risk. Below are the principal downsides and a direct counterargument to the bullish thesis.
- AI competition and disintermediation: New AI-first vendors could replicate parts of RELX's offerings with lower price points or embed themselves into workflows, pressuring growth and forcing accelerated investment that compresses margins.
- Valuation compression persists: If investors continue to fear a broad sector derating, RELX's multiple could compress further despite healthy fundamentals, leaving the stock rangebound or lower for an extended period.
- Exhibitions and cyclical exposure: The Exhibitions segment is more cyclical and sensitive to corporate budgets; a slowdown here could hit near-term topline even if subscriptions remain stable.
- Regulatory and data-privacy headwinds: Stricter privacy laws or limits on data use in key markets could increase compliance costs and restrict some of the company's data-driven services.
- FX and macro sensitivity: As a London-headquartered business with global revenues, RELX is exposed to currency swings and regional demand weakness (UK GDP growth has been fragile in recent quarters).
Counterargument: The most plausible bear case is that AI-native competitors scale quickly, offering cheaper or more automated alternatives that erode RELX's share in higher-growth segments like legal analytics or insurance underwriting. If those competitors reach parity on accuracy and integration while undercutting pricing, RELX would be forced into heavy investment cycles to defend share, compressing earnings and justifying a lower multiple.
What would change my mind
I will reassess the trade if any of the following occur: (1) public proof of significant market-share losses to AI-native competitors, (2) a string of quarterly misses indicating durable revenue deceleration, (3) margin erosion that shows the company is investing to defend obsolete offerings rather than developing new high-margin products, or (4) a technical break below $33 with volume confirming capitulation. Conversely, sustained evidence of accelerating subscription revenue, improved margins and another round of large enterprise deployments would strengthen the bullish case and justify a higher target.
Conclusion
RELX is not a speculative AI play; it's a high-quality information franchise that has been unfairly dragged lower in a sector-wide re-rating. The stock offers a mid-term asymmetric trade: limited downside with a disciplined stop and a plausible upside to $44 if sentiment stabilizes and enterprise spend continues. The combination of pricing power in legal services, recurring revenue, a modest dividend and constructive momentum supports a medium-risk long position for 45 trading days.
Key tactical items
- Enter near $36.33; size the position so the $33 stop is within your risk budget.
- Watch for confirming catalysts: enterprise deployment announcements and quarterly KPIs that show subscription resilience.
- Re-evaluate on any close below $33 or if new competitive threats emerge with clear evidence of share loss.